Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

Extended abstract deadline for International Pandemic Sciences Conference 2025

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025  has been extended to 23:59 GMT on Wednesday 26 February.

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.

New partnership to advance public health and life science research collaboration in West Africa

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Abstract submissions open for International Pandemic Sciences Conference 2025

Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.

Pig research paves way for human respiratory vaccine development

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

Registration now open for International Pandemic Sciences Conference 2025

Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.

Optimising testing for disease surveillance with machine learning

A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.

Nipah Virus Research Day showcases cross-disciplinary advances

Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu

Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.

Reconstructing a lifetime of flu infections to understand long-term trends

Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.

£5.5m funding boost for health protection research on emerging and zoonotic infections

University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.

Moh Family Foundation visit highlights vital support for pandemic preparedness research

The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation’s generous support.

Large-scale study on Long Covid highlights urgent, global need for investment

A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.

Study suggests possible new transmission route for highly pathogenic avian influenza

Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.

Study explores aerosol immunisation as path to broadly protective influenza vaccine

Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.

New multidisciplinary programme to develop digital pandemic tools

The Oxford Martin Programme on Digital Pandemic Preparedness will be co-led by researchers affiliated with the Pandemic Sciences Institute.

PSI seminar series launches with talk on pandemic control measures

Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.

Oxford Vaccine Group announces return of science and healthcare podcast

A brand-new season of The Oxford Colloquy – a podcast series of conversations with leading experts in science and healthcare – is launched this week by Oxford Vaccine Group.

PSI collaborates with Oxford’s History of Science Museum on new exhibition

The latest exhibition "A Healthy Future for All?" explores the science driving advancements in healthcare

Load More